Amyloid-PET and prediction of future cognitive decline and amyloid accumulation


  • A specific amyloid beta-positron emission tomography (Aβ-PET) threshold is predictive of cognitive decline in clinically normal individuals.

Why this matters

  • A major focus of current research and clinical trials is earlier intervention for dementia-related-disorders; and imaging techniques can be useful for classification of both normal and abnormal thresholds of associated proteins such as Aβ.

  • Optimized thresholds of Aβ-PET can help inform future research and clinical trials targeting early Aβ accumulation and cognitive decline associated with neurodegenerative disorders.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.